Destination
USA, Puerto Rico and US Virgin Islands
- Latest exports
- $11.0M
- Market share
- 15.4%
- Growth
- +62.4%
- Access
- 0% tariff
- Signal
- Slowing
T3 · Product exporter position
Germany exports of Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments (HS 300670)
See where Germany stands in pharmaceutical goods: gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments: export scale, destination breadth, market position, growth, and reported trade history.
Latest exports
$37.2MLatest observed lane totalDestination markets
126Reported active marketsThree-year growth
+11.3%Annualized changeDestination HHI
1,147Destination concentrationWeighted share
17%Reported market positionExporter evidence
How strong is Germany in Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments?
Reported exporter totals and calculated indicators for HS 300670. Values retain their observed coverage period.
Exporter scale
Latest exports$37.2M
Current 2024 exports$36.9M
Three-year average$35.2M
Historical peak$1.0B
Market position
Active destinations126
Destination HHI1,147
Weighted share17%
Share change-0.8 pp
Competitiveness
Three-year growth+11.3%
Volatility1.6
Maximum drawdown99.8%
TrendRapid growth
| Measure | Value | What it describes |
|---|---|---|
| Exporter | Germany | Country represented by this profile |
| Latest observed exports | $37.2M | Sum of latest observed destination-lane values |
| Current 2024 exports | $36.9M | Common-year comparison where reported |
| Three-year growth | +11.3% | Annualized change in exporter totals |
| Five-year growth | +5.1% | Annualized change in exporter totals |
| Leading destination | USA | Destination with the largest observed export value |
| Leading destination share | 29.6% | Share of observed exporter totals |
| Destination concentration | 1,147 | HHI across destination markets |
| Weighted share change | -0.8 pp | Value-weighted latest change in market share |
| Limited-history lanes | 10.4% | Share of lanes with shorter history |
Destination markets
Where does Germany sell pharmaceutical goods: gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments?
Leading destination observations ranked by reported export value, with market position and access context.
| Destination | Latest exports | Market share | Growth | Access | Signal |
|---|---|---|---|---|---|
| USA, Puerto Rico and US Virgin Islands | $11.0M | 15.4% | +62.4% | 0% tariff | Slowing |
| United Kingdom | $3.8M | 18.4% | +0.7% | FTA reported | Declining |
| Netherlands | $2.3M | 0.2% | -13.3% | FTA reported | Declining |
| France | $1.9M | 11.9% | +4.2% | FTA reported | Declining |
| Australia | $1.5M | 13.1% | +49.6% | 0.1% tariff | Slowing |
| Canada | $503.4K | 4.7% | +4.9% | FTA reported | Declining |
| China | $455.7K | 2.6% | -12.1% | 0.3% tariff | Declining |
Destination
United Kingdom
- Latest exports
- $3.8M
- Market share
- 18.4%
- Growth
- +0.7%
- Access
- FTA reported
- Signal
- Declining
Destination
Netherlands
- Latest exports
- $2.3M
- Market share
- 0.2%
- Growth
- -13.3%
- Access
- FTA reported
- Signal
- Declining
Destination
France
- Latest exports
- $1.9M
- Market share
- 11.9%
- Growth
- +4.2%
- Access
- FTA reported
- Signal
- Declining
Destination
Australia
- Latest exports
- $1.5M
- Market share
- 13.1%
- Growth
- +49.6%
- Access
- 0.1% tariff
- Signal
- Slowing
Destination
Canada
- Latest exports
- $503.4K
- Market share
- 4.7%
- Growth
- +4.9%
- Access
- FTA reported
- Signal
- Declining
Destination
China
- Latest exports
- $455.7K
- Market share
- 2.6%
- Growth
- -12.1%
- Access
- 0.3% tariff
- Signal
- Declining
Price intelligence
How does Germany's price position vary?
Price comparisons are shown where market-level unit-value observations are available. They describe reported trade values and quantities, not quoted selling prices.
Highest reported price
Ecuador: $87.5M / ton.
Lowest reported price
Gambia: $194.9 / ton.
Median price
$20.5K / ton across reported markets.
Export trend
Reported export history
Annual observations for Germany and HS 300670 where available.
| Year | Exports | Year-on-year change | Active destinations |
|---|---|---|---|
| 2010 | $18.1M | +3.6% | 127 |
| 2011 | $19.5M | +7.7% | 122 |
| 2012 | $17.2M | -11.8% | 139 |
| 2013 | $20.2M | +17.4% | 125 |
| 2014 | $20.9M | +3.7% | 122 |
| 2015 | $17.2M | -17.9% | 124 |
| 2016 | $18.3M | +6.4% | 138 |
| 2017 | $20.4M | +11.5% | 123 |
| 2018 | $32.3M | +58.6% | 122 |
| 2019 | $28.8M | -10.8% | 127 |
| 2020 | $32.9M | +14.1% | 121 |
| 2021 | $26.7M | -18.7% | 126 |
| 2022 | $27.3M | +2.2% | 123 |
| 2023 | $41.4M | +51.7% | 120 |
| 2024 | $36.9M | -11% | 126 |
Exporter context
Germany economy and trade network
The exporter profile adds country-level trade and structural context to the selected product position. These indicators describe the country overall and are not limited to HS 300670.
Germany has reported exports of $1.6T and a trade balance of $239.2B in 2024.
Available structural indicators include 64.1% trade openness, 22.1% investment, and 1,080 active trade partners.
Reported values
Export totals and destination values describe reported merchandise trade for the stated exporter, HS6 classification, and available year.
Calculated indicators
Growth, concentration, weighted share, volatility, drawdown, and price comparisons are calculated from reported observations.
Coverage
Missing values remain “Not reported”. Country-level indicators are presented separately from product-level observations.
Frequently asked questions
Questions about Germany pharmaceutical goods: gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments exports
Quick answers based on the figures and coverage shown on this page.
How strong is this exporter?+
Use latest exports, destination breadth, growth, concentration, and weighted share together rather than relying on one measure.
Which markets are most important?+
The destination table ranks reported markets by the latest observed export value.
Does the price section show quotes?+
No. It summarizes reported trade value and quantity observations converted to unit values.
What should be checked next?+
Compare this exporter with buyer markets, corridors, and the product overview before making a commercial decision.